Your prediction
Pros and Cons of Exicure Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
News
Exicure Posts Wider Loss in Fiscal Q2
Exicure (NASDAQ:XCUR), a biotechnology company that recently pivoted its business model following the acquisition of GPCR Therapeutics USA Inc, reported its second quarter 2025 earnings on August 8
